Evidence map›Paper›PMID 37899989›Full record

ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2023

CD34

Antti Samuli Turunen, Outi Kuittinen, Hanne Kuitunen, Kaija Vasala, Karri Penttilä, Minna Harmanen, Leena Keskinen, Pentti Mäntymaa, Jukka Pelkonen, Ville Varmavuo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Stem Cell Mobilization, Collection, and Processing.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Antti Samuli TurunenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Outi KuittinenInstitute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Hanne KuitunenCancer Centre, Oulu University Hospital, Oulu, Finland.
Kaija VasalaDepartment of Oncology, Central Hospital of Central Finland, Jyväskylä, Finland.
Karri PenttiläDepartment of Medicine, Savonlinna Central Hospital, Savonlinna, Finland.
Minna HarmanenInstitute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Leena KeskinenDepartment of Oncology, Tampere University Hospital, Tampere, Finland.
Pentti MäntymaaLaboratory Centre of Eastern Finland, Kuopio, Finland.
Jukka PelkonenLaboratory Centre of Eastern Finland, Kuopio, Finland.
Ville VarmavuoDepartment of Medicine, Kymenlaakso Central Hospital, Kotka, Finland.
Esa JantunenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Anu PartanenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Eastern Finland Laboratory Center · FIKuopio University Hospital · FIOulu University Hospital · FICentral Finland Health Care District · FIFinnish Medicines Agency Fimea · FIKymenlaakson keskussairaala · FINorth Karelia Central Hospital · FITampere University Hospital · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgound: Autologous stem cell transplantation (ASCT) is a standard treatment in transplant-eligible mantle cell lymphoma (MCL) patients after first-line chemoimmunotherapy. Study Design and Methods: This prospective multicenter study evaluated the impact of CD34 Results: During CD34 Conclusions: Better mobilization capacity and higher graft CD3

Indexed as

AutologousCD34+ cellsCD4+CD8+ cellsGraft compositionLymphocytesMantle cell lymphomaMobilizationTransplantation

Identifiers

PMID37899989
PMCPMC10601603
OpenAlexW4387758517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.